ITGR (Integer Holdings) Risk Assessment

View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Integer Holdings is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Integer Holdings's Risk Assessment

For the Medical Devices subindustry, Integer Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integer Holdings's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Integer Holdings's Risk Assessment falls into.

Integer Holdings (NYSE:ITGR) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Integer Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of Integer Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Integer Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024

Website

https://www.integer.net

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

Executives

Jean M. Hobby	director	10000 WEHRLE DRIVE, CLARENCE NY 14031
Martin C Maxwell	director	PARKER HANNIFIN CORPORATION, 6035 PARKLAND BLVD, CLEVELAND OH 44124
John A Harris	officer: VP, Operations Cardio & Vascul	10000 WEHRLE DRIVE, CLARENCE NY 14031
James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Payman Khales	officer: President, C&V	10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn	officer: SVP, Strategy and Business Dev	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Tommy P Thomas	officer: VP, Corporate Controller	10000 WEHRLE DRIVE, CLARENCE NY 14031
Donald J Spence	director	C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jim Stephens	officer: President, CRM & Neuro	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith	officer: VP, Interim CFO	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic	director	1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey	director	1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Marshall Mcalister C Ii	officer: SVP, Gen Counsel & Secretary	1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226